Historical Stock Price
ETFs Holding CBIO »    CBIO Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
06/14/2021 $4.52 $4.63 $4.44 $4.47 130.50K
06/15/2021 $4.49 $4.49 $4.24 $4.28 215.70K
06/16/2021 $4.28 $4.39 $4.21 $4.33 227.60K
06/17/2021 $4.30 $4.47 $4.29 $4.43 163.10K
06/18/2021 $4.34 $4.43 $4.29 $4.33 251.40K
Catalyst Biosciences is a research and clinical development biopharmaceutical company engaged in protease engineering, discovery and translational research, clinical development and manufacturing. Co. has a range of protease engineering platform that feeds its research and development pipeline. Co. is focusing on the clinical development of MarzAA for Hemophilia A and B and DalcA for Hemophilia B. MarzAA is Phase 3 ready and DalcA, which is in Phase 2b. MarzAA for routine prophylaxis to prevent bleeding episodes in individuals with Hemophilia A and B with inhibitors and DalcA for routine prophylaxis to prevent bleeding episodes for Hemophilia B patients.
CBIO historical stock prices picture
Catalyst Biosciences (CBIO) has the following price history information. Looking back at CBIO historical stock prices for the last five trading days, on June 14, 2021, CBIO opened at $4.52, traded as high as $4.63 and as low as $4.44, and closed at $4.47. Trading volume was a total of 130.50K shares. On June 15, 2021, CBIO opened at $4.49, traded as high as $4.49 and as low as $4.24, and closed at $4.28. Trading volume was a total of 215.70K shares. On June 16, 2021, CBIO opened at $4.28, traded as high as $4.39 and as low as $4.21, and closed at $4.33. Trading volume was a total of 227.60K shares. On June 17, 2021, CBIO opened at $4.30, traded as high as $4.47 and as low as $4.29, and closed at $4.43. Trading volume was a total of 163.10K shares. On June 18, 2021, CBIO opened at $4.34, traded as high as $4.43 and as low as $4.29, and closed at $4.33. Trading volume was a total of 251.40K shares.

CBIO Historical Stock Prices By Date:

CBIO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Catalyst Biosciences shares, starting with a $10,000 purchase of CBIO, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 06/20/2011
End date: 06/18/2021
Start price/share: $2,239.65
End price/share: $4.33
Starting shares: 4.46
Ending shares: 7.11
Dividends reinvested/share: $59.74
Total return: -99.69%
Average Annual Total Return: -43.91%
Starting investment: $10,000.00
Ending investment: $30.77
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/20/2011
End date: 06/18/2021
Start price/share: $2,239.65
End price/share: $4.33
Dividends collected/share: $59.74
Total return: -97.14%
Average Annual Total Return: -29.90%
Starting investment: $10,000.00
Ending investment: $286.26
Years: 10.00
Date Close
06/14/2021$4.47
06/15/2021$4.28
06/16/2021$4.33
06/17/2021$4.43
06/18/2021$4.33
CBIO is categorized under the Healthcare sector; below are some other companies in the same sector:

CBLI Historical Stock Prices
CBM Historical Stock Prices
CBMG Historical Stock Prices
CBMX Historical Stock Prices
CBMXW Historical Stock Prices
CBPO Historical Stock Prices
CBRX Historical Stock Prices
CBST Historical Stock Prices
CBSTZ Historical Stock Prices
CBYL Historical Stock Prices

Also explore: CBIO shares outstanding history

CBIO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.